Díaz ML, Arellano SME, del Valle CMG, Miranda DA, Rodríguez RG, Montero AA

Language: Spanish
References: 27
Page: 16-22
PDF size: 104.45 Kb.

ABSTRACT

Introduction: Neuromuscular electrical stimulation and botulinum toxin type A injections have been independently used in the pediatric and adult population for the management of spasticity with varying results. However studies are lacking in the combined use of these two modalities for the treatment of pediatric spasticity. Objective: To assess the effectivity of combined treatment with neuromuscular electrical stimulation and botulinum toxin in pediatric patients with spasticity secondary to cerebral palsy. Material and methods: Eight ambulatory pediatrics patients with spastic hemiparesis, without cognitive, visual or conduct alterations. Botulinum toxin was applied on the patients spastic agonist muscles, low frequency bifasic simetric current was applied on antagonist muscles. Patients also received occupational and physical therapy. Movement analysis was done with electromagnetic sensors, manual functionality was assessed with the Jebsen manual function test at the beginning and end of treatment. Results: Descriptive and comparative statistics were done with the Kruskal-Wallis and Wilcoxon test. Significant improvement was observed in global manual functioning (p = 0.03). Spasticity and range of movement did not vary significantly. Conclusions: Our study shows that the combined use of low dose BTA injections and NMES at low frequency, improve function of hemiparetic extremity.

REFERENCES

1. Barry S. Russman, MD. Cerebral palsy: A rational Approach to a treatment protocol and the role of botulinum toxin in treatment. Muscle and nerve. Suplement 6; 1997: S181-191.

2. Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity. Am J Phys Med Rehabil 2003; 82: 284-89.

3. Wright P, Granat M. Therapeutic effects of functional electrical stimulation of the upper limb of eight children with cerebral palsy. Dev Med Child Neurol 2000; 42: 724-7.

4. Grazko MA, Polo KB, Bahman J. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995; 45: 712-17.

5. Seib TP, Price R, Reyes MR, Justus F. The quantitative measurement of spasticity: Effect of cutaneous electrical stimulation. Archives Phys Med Rehabil 1994; 75: 746-50.

6. Jacobs JM. Management options for the child with spastic cerebral palsy. Orthopaedic Nursing 2001; 20(3): 53-60.

7. Wong V, Ng Asit P. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy. Journal of Child Neurology 2002; 17(2): 138-142.

8. Koman LA, Mooney JF III, Smith B et al. Management of cerebral palsy with botulinum A-toxin: preliminary investigation. J Pediatr Orthop 1993; 13: 489-95.

9. Fatal-Valevski A, Giladi N, Domanievitz D, Zuk L, Masterman R, Harel S, Wientroub S, Hayek S. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy. J Child Neurol 2002; 17(4): 272-7.

10. Hurvitz EA, Conti GE, Flansburg EL et al. Motor control testing of upper limb function after botulinum toxin injection: A case study. Arch Phys Med Rehabil 2000; 81: 1408-15.

11. Fehlings D, Rang M, Glazier J et al. An evaluation of botulinum A toxin injection to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 2000; 137: 331-7.

12. Hurvitz EA, Conti GE, Brown SH. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. Arch Phys Med Rehabil 2003; 84: 444-54.

13. Simpson DM, Alexander DN, O´Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial. Neurology 1996; 46(5): 1306-10.

14. Norwalk CT. Clinical Electrotherapy. Appeton and Large, 1999: 225- 256.

15. King TI, II. The effect of neuromuscular electrical stimulation in reducing tone. The American Journal of Occupational Therapy 1996; 50(1): 62-64.

16. Dali C, Juul F, Anker S et al. Threshold electrical stimulation in ambulant children with CP: a randomized double-blind placebo controlled clinical trial. Dev Med Child Neurol 2002; 44: 364-9.

17. Hesse S, Jahnke MT, Luecke D, Mauritz KH. Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995; 201(1): 37-40.

18. Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil 1998; 12(5): 381-8.

19. Sommerfelt K, Markestad T, Borg K, Saetesdal I. Therapeutic electrical stimulation in cerebral palsy: a randomized, controlled, crossover trial. Dev Med Child Neurol 2001; 43: 609-13.

20. Carmick J. Clinical Use of nueromuscular electrical stimulation for children with cerebral palsy, Part 1: Lower extremity. Phys Ther 1993; 73: 505-13.

21. Carmick J. Managing equines in children with cerebral palsy: electrical stimulation to strengthen the triceps surae muscle. Dev Med and Child Neurol 1995; 37: 965-75.

22. Carmick J. Use of neuromuscular electrical stimulation and (corrected) dorsal splint to improve the hand function of a child with spastic hemiparesis. Phys Ther 1997; 77(6): 661-71.

23. Gregson JM, Leathley M. Reliability of the tone assesment scale and the modified ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil 1999; 80: 1013.

24. Terman L. Medida de la inteligencia. Método para el empleo de las pruebas del Stanford–Binet. 9ª. Ed. Espasa-Calpe. Madrid. 1975.

25. Wechsler D. WPPSI-Español. Escala de inteligencia para los niveles preescolar y primario. Manual Moderno, México, DF-Santafé de Bogotá 1981.

26. Hackel M. Changes in hand function in the aging adult as determined by the Jebsen test of hand function. Physical Therapy 1992; 72(5): 373.

27. Papazian O, Alfonso I. Tratamiento de la parálisis cerebral infantil. Rev Neurol 1997; 25: 728-739.